Celivarone in patients with an implantable cardioverter-defibrillator: Adjunctive therapy for the reduction of ventricular arrhythmia-triggered implantable cardioverter-defibrillator interventions

Heart Rhythm

Volumn 9, Issue 2, 2012, Pages 217-224.e2

  Gojkovic, Olivera ^a   Aliot, Etienne M ^b   Capucci, Alessandro ^c   Connolly, Stuart J ^d   Crijns, Harry ^e   Hohnloser, Stefan H ^f   Kulakowski, Piotr ^g   Roy, Denis ^h   Radzik, David ⁱ   Singh, Bramah N ^j   Kowey, Peter R ^a  

^a LANKENAU HOSPITAL   (United States)

^b CHU NANCY BRABOIS   (France)

^c Ospedale Civile   (Italy)

^d University Hamilton   (Canada)

^e MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^f GOETHE UNIVERSITY   (Germany)

^g GROCHOWSKI HOSPITAL   (Poland)

^h MONTREAL HEART INSTITUTE   (Canada)

ⁱ SANOFI   (France)

^j VETERANS AFFAIRS MEDICAL CENTER   (United States)

more..

Author keywords

Antiarrhythmic drugs; Celivarone; Implantable cardioverter defibrillator; Ventricular arrhythmia; Ventricular tachycardia

Indexed keywords

CELIVARONE; CREATININE;

ABDOMINAL PAIN; ADULT; ANGINA PECTORIS; ARTHRALGIA; ARTICLE; BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONGESTIVE HEART FAILURE; CONSTIPATION; CONTROLLED STUDY; COUGHING; CREATININE BLOOD LEVEL; DEFIBRILLATOR; DIARRHEA; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; DYSPNEA; FATIGUE; FEVER; HEADACHE; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART LEFT VENTRICLE FAILURE; HEART PALPITATION; HEART RATE; HEART RIGHT VENTRICLE FAILURE; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPOTENSION; INSOMNIA; LUNG EDEMA; LUNG FIBROSIS; LUNG TOXICITY; MAJOR CLINICAL STUDY; MORBIDITY; MULTICENTER STUDY; MUSCLE SPASM; MYALGIA; NAUSEA; PERIPHERAL EDEMA; PHASE 2 CLINICAL TRIAL; PRESYNCOPE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; RECURRENT DISEASE; RHINOPHARYNGITIS; RISK BENEFIT ANALYSIS; RISK REDUCTION; SIDE EFFECT; SINUSITIS; SLEEP DISORDER; SYNCOPE; THORAX PAIN; THYROID DISEASE; TORSADE DES POINTES; TREATMENT DURATION; TREATMENT OUTCOME; VOMITING; WEIGHT GAIN;

EID: 84856213869     PISSN: 15475271     EISSN: 15563871     Source Type: Journal    
DOI: 10.1016/j.hrthm.2011.09.073     Document Type: Article

References (24)

1. J.B. Van Rees, C.J.W. Borleffs, M.K. De Bie Inappropriate implantable cardioverter-defibrillator shocks J Am Coll Cardiol 57 2011 556 562
2. P. Dorian, R.A. Hussein, S.H. Hohnloser Azimilide reduces emergency department visits and hospitalizations in patients with an implantable cardioverter-defibrillator in a placebo-controlled clinical trial J Am Coll Cardiol 52 2008 1076 1083
3. A.J. Moss, W. Zareba, J. Hall Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction N Engl J Med 346 2002 877 883
4. G.H. Bardy, K.L. Lee, D.B. Mark Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure N Engl J Med 352 2005 225 237
5. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators A comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias N Engl J Med 337 1997 1576 1583
6. J.E. Poole, G.W. Johnson, A.S. Hellkamp Prognostic importance of defibrillator shocks in patients with heart failure N Engl J Med 359 2008 1009 1017
7. H. Van Herendael, A. Pinter, K. Ahmad Role of antiarrhythmic drugs in patients with implantable cardioverter defibrillators Europace 12 2010 618 625
8. S.J. Connolly, P. Dorian, R.S. Roberts Comparison of β-blockers, amiodarone plus β-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators JAMA 295 2006 165 171
9. P. Dorian, M. Borggrefe, H.R. Al-Khalidi Placebo-controlled, randomized clinical trial of azimilide for prevention of ventricular tachyarrhythmias in patients with an implantable cardioverter defibrillator Circ J 110 2004 3646 3654
10. J.S. Steinberg, J. Martins, S. Sadanandan Antiarrhythmic drug use in the implantable defibrillator arm of the Antiarrhythmics Versus Implantable Defibrillator (AVID) study Am Heart J 142 2001 520 529
11. V. Kuhlkamp, C. Mewis, J. Mermi Suppression of sustained ventricular tachyarrhythmias: a comparison of d,l-sotalol with no antiarrhythmic drug treatment J Am Coll Cardiol 33 1999 46 52
12. A. Pacifico, S.H. Hohnloser, J.H. Williams Prevention of implantable-defibrillator shocks by treatment with sotalol N Engl J Med 340 1999 1855 1862
13. J.W. Mason Electrophysiologic Study versus Electrocardiographic Monitoring Investigators A comparison of seven antiarrhythmic drugs in patients with ventricular tachyarrhythmias N Engl J Med 329 1993 452 458
14. I. Singer, H. Al-Khalidi, I. Niazi Azimilide decreases recurrent ventricular tachyarrhythmias in patients with implantable cardioverter defibrillators J Am Coll Cardiol 43 2004 39 43
15. Van Herendael, P. Dorian Amiodarone for the treatment and prevention of ventricular fibrillation and ventricular tachycardia Vasc Health Risk Man 6 2010 465 472
16. P. Gautier, M. Serre, S. Cosnier-Pucheu In vivo and in vitro antiarrhythmic effects of SSR149744C in animal models of atrial fibrillation and ventricular arrhythmias J Cardiovasc Pharmacol 45 2005 125 135
17. P. Gautier, E. Gillemare, L. Dijandjighian In vivo and in vitro characterization of antiarrhythmic agent SSR149744C: electrophysiological, anti-adrenergic, and anti-angiotensin II effects J Cardiovasc Pharmacol 44 2004 244 257
18. S. Kathofer, D. Thomas, C.A. Karle The novel antiarrhythmic drug dronedarone: comparison with amiodarone Cardiovasc Drug Rev 23 2005 217 230
19. T.M. Therneau, P.M. Grambsch Modeling Survival Data Extending the Cox Model Statistics for Biology and Health 2000 Springer New York
20. Y. Hochberg A sharper Bonferroni procedure for multiple test of significance Biometrika 75 1988 800 803
21. L. Kober, C. Torp-Pedersen, J.J. McMurray Increased mortality after dronedarone therapy for severe heart failure N Engl J Med 358 2008 2678 2687
22. I. Singer, H. Al-Khalidi, I. Niazi Azimilide decreases recurrent ventricular tachyarrhythmias in patients with implantable cardioverter defibrillators J Am Coll Cardiol 43 2004 39 43
23. Y. Hochberg, A. Tamhane Multiple Comparison Procedure 1987 Wiley New York
24. Y. Hochberg A sharper Bonferroni procedure for multiple test of significance Biometrika 75 1988 800 803